ClariVest Asset Management’s Spyre Therapeutics SYRE Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,365	Closed	-$424K	–	774
2022 Q1	$424K	Buy	7,365 +368	+5%	+$21.2K	0.02%	408
2021 Q4	$832K	Buy	+6,997	New	+$832K	0.03%	356